Toxicologist: FDA’s NDI guidance is entirely reasonable

By Elaine Watson

- Last updated on GMT

Related tags New dietary ingredients Dietary supplement

Kruger: Think about this from a consumer confidence perspective
Kruger: Think about this from a consumer confidence perspective
Many dietary ingredients used in supplements today bear little resemblance to ingredients that were assumed to be ‘grandfathered in’ post the 1994 Dietary Supplements Health and Education Act, making a fresh safety analysis eminently reasonable if extraction methods have changed, according to one toxicologist.

Claire Kruger is chief executive of consultancy Spherix Health Sciences and has helped several firms prepare premarket notifications for a number of dietary supplements.

Kruger was speaking to NutraIngredients-USA.com following the publication of the FDA’s controversial draft guidance on new dietary ingredients (NDIs), which stipulates that changes to the manufacturing process, new solvents or new extraction methods could trigger an NDI notification if they alter the chemical composition or structure of the ingredient.

She said: “There are valid concerns about the composition changing. If you’ve got an ethanol extract and then you throw it down a chromatography column, it’s valid to look at it again.”

A lot has changed since 1994

A lot had changed since 1994, she added: “We have far more complex kinds of products now that were not on the market in 1994. What have we done to demonstrate their safety? It’s all very well to say that the population had been consuming this substance for years and years, but what if what is actually on sale now has a very different composition or chemical profile?

“What about the differences in impurity profiles and the context in which the component will be delivered?”

She added: “It ​[the guidance] does sound scary, and I can fully understand why there might be some hyperventilation going on. But we need to think about this from a consumer confidence perspective. If you are introducing a new ingredient to the market and people are ingesting it, it should go through a rigorous and comprehensive process.

“The proliferation of new dietary ingredients ​[and the correspondingly low number of NDI notifications submitted to the FDA since 1994] makes us ask the question very reasonably: Is the safety of these ingredients being assured? The fact so few companies have notified the FDA leads me to suggest that there is great ignorance out there … so the clarity this guidance provides is a positive step."

It was also important to stress that the guidance​was “not creating a new process or ‘raising the bar’, it’s just clarifying what the existing process actually is”, ​she added.

Self-affirmed GRAS? No need for NDI…

Firms looking for assistance should look at the NDI and GRAS notifications already submitted, said Kruger. But they should also bear in mind that toxicology studies were not always required in submissions.

“We can sometimes look at the plant and its chemistry and do a tox evaluation from the literature.”

As for the news that FDA would accept both self-affirmed and FDA-affirmed GRAS status in lieu of an NDI filing, which one lawyer claimed had left him “flabbergasted​”, she said:

The process by which self-affirmed GRAS is completed is not subject to FDA review and I would have liked to have seen the FDA notification route more strongly encouraged​ [in the draft NDI guidance].

Click here​ to read our interview with the FDA's Dan Fabricant on the new guidance.

Related news

Show more

Related products

show more

PlexoZome®: Genuine Liposomal Delivery Technology

PlexoZome®: Genuine Liposomal Delivery Technology

Content provided by Gencor | 06-Nov-2023 | White Paper

This White Paper looks at PlexoZome®, a scientifically proven complex liposomal technology. These genuine liposomes are verified through TEM & Cryo-TEM...

The Art of Organic Certification

The Art of Organic Certification

Content provided by FoodChain ID | 23-Oct-2023 | White Paper

The organic food market has experienced remarkable growth over the past decade, providing a major opportunity for food brands and manufacturers to tap...

Perfect Match: Brand Owner, CDMO, Online Retailer

Perfect Match: Brand Owner, CDMO, Online Retailer

Content provided by Gemini Pharmaceuticals, Inc | 27-Sep-2023 | White Paper

In the past couple of years, the online retailer marketplace has become the dominant place for Brand Owners to increase sales and brand awareness.

Related suppliers

2 comments

NDI: not unreasonable, but impractical

Posted by Bill Sardi,

Well, of course, consultants like NDI because it means more business for them. So let's test everything. So what supplement on store shelves today is the same as it was in 1994? Probably none. So the entire industry has to subject virtually every product for toxocoligal testing. And at what cost? Many products simply do not generate sufficientb revenues to justify testing. And just how would FDA propose to handle these thousands of NDI applications? And what is the end point we are trying to prevent? Where are the dead bodies and birth defective babies? This appears to be an expensive paper-work drill that gleefully is promoted by bureaucrats. So now that we have all of our paperwork in order, have we killed the industry?

Report abuse

Supplements are safer than tap water, aspirin, salt, even food

Posted by Gordon,

>>>>>Toxicologists control CODEX and the EU regulations that have wiped out the European supplement industry. Beware.<<<<<

• FDA is demanding safety data on virtually every dietary supplement that has multiple ingredients, and without evidence of a clear and present danger

• Poison control center data does not indicate there are any deaths from supplements, and few other side effects

• If there is nothing troubling in the new FDA NDI Guidance, why was it released late in the afternoon under the cloak of a holiday weekend?

[Bill Sardi commenting on Vasilos Frankos, HERBALIFE, former director of FDA’s dietary supplements division support of this over-reaching NDI Guidance]

Report abuse

Follow us

Products

View more

Webinars